Bed Bath & Beyond (NASDAQ:BBBY) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

BBBY has been the subject of a number of other research reports. Zacks Investment Research upgraded Bed Bath & Beyond from a “hold” rating to a “buy” rating and set a $31.00 price objective for the company in a research note on Tuesday, September 5th. Credit Suisse Group reiterated a “neutral” rating and set a $25.00 price objective (down previously from $33.00) on shares of Bed Bath & Beyond in a research note on Wednesday, September 20th. Bank of America reiterated an “underperform” rating and set a $22.00 price objective (down previously from $27.00) on shares of Bed Bath & Beyond in a research note on Wednesday, September 20th. Telsey Advisory Group reduced their price objective on Bed Bath & Beyond from $32.00 to $21.00 and set a “market perform” rating for the company in a research note on Wednesday, September 20th. Finally, Robert W. Baird set a $23.00 price objective on Bed Bath & Beyond and gave the company a “hold” rating in a research note on Tuesday, October 31st. Nine research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $27.88.

Bed Bath & Beyond (NASDAQ BBBY) traded up $0.03 during midday trading on Friday, hitting $22.42. The company’s stock had a trading volume of 5,850,226 shares, compared to its average volume of 3,331,478. The stock has a market cap of $3,210.00, a price-to-earnings ratio of 5.47 and a beta of 1.04. Bed Bath & Beyond has a twelve month low of $19.07 and a twelve month high of $48.83. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.77 and a quick ratio of 0.33.

Bed Bath & Beyond (NASDAQ:BBBY) last released its quarterly earnings data on Tuesday, September 19th. The retailer reported $0.67 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.28). The company had revenue of $2.94 billion for the quarter, compared to analysts’ expectations of $3.01 billion. Bed Bath & Beyond had a net margin of 4.64% and a return on equity of 21.74%. The business’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.11 EPS. sell-side analysts expect that Bed Bath & Beyond will post 2.98 earnings per share for the current year.

Several institutional investors have recently made changes to their positions in the stock. Gargoyle Investment Advisor L.L.C. increased its stake in shares of Bed Bath & Beyond by 0.7% in the 2nd quarter. Gargoyle Investment Advisor L.L.C. now owns 64,346 shares of the retailer’s stock valued at $1,956,000 after purchasing an additional 425 shares in the last quarter. Pacer Advisors Inc. increased its stake in Bed Bath & Beyond by 3.4% during the 2nd quarter. Pacer Advisors Inc. now owns 23,286 shares of the retailer’s stock worth $708,000 after buying an additional 757 shares in the last quarter. Analyst IMS Investment Management Services Ltd. increased its stake in Bed Bath & Beyond by 2.5% during the 2nd quarter. Analyst IMS Investment Management Services Ltd. now owns 46,694 shares of the retailer’s stock worth $1,419,000 after buying an additional 1,150 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in Bed Bath & Beyond by 0.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 179,391 shares of the retailer’s stock worth $5,453,000 after buying an additional 1,260 shares in the last quarter. Finally, Meiji Yasuda Life Insurance Co increased its stake in Bed Bath & Beyond by 15.8% during the 2nd quarter. Meiji Yasuda Life Insurance Co now owns 9,540 shares of the retailer’s stock worth $290,000 after buying an additional 1,300 shares in the last quarter. Hedge funds and other institutional investors own 91.27% of the company’s stock.

WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/12/01/bed-bath-beyond-bbby-upgraded-to-buy-by-valuengine.html.

Bed Bath & Beyond Company Profile

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

Analyst Recommendations for Bed Bath & Beyond (NASDAQ:BBBY)

Receive News & Stock Ratings for Bed Bath & Beyond Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond Inc. and related stocks with our FREE daily email newsletter.